News Releases
Dec 1 2020
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Nov 24 2020
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2021 After Market Close on December 2, 2020
Sep 15 2020
Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020
Sep 10 2020
Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference
Sep 1 2020
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments
Aug 31 2020
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Aug 26 2020
Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for Clinical Development of Novel Human Monoclonal Antiviral Antibody
Aug 25 2020
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2021 After Market Close on September 1, 2020
Aug 20 2020
Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine
Aug 6 2020
Avid Bioservices Selected By Iovance Biotherapeutics to Lead Process Development Through CGMP Manufacturing of Novel IL-2 Analog, IOV-3001